Hepatitis B surface antigen (HBsAg) quantification has recently been introduced to guide treatment in chronic hepatitis B virus (HBV) patients.

The hepatitis B virus (HBV) causes infection in the liver that can lead to cirrhosis, liver cancer, and premature death. The disease is not widely…

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease globally, and it is expected to rise even further as a result of the…

Non-alcoholic fatty liver disease (NAFLD) is a cluster of pathological liver conditions of emerging importance in overweight and obese children.

Alternatives for liver transplantation in severe liver disease are urgently needed in view of the limited availability of donor livers.

This Bristol Myers Squibb-sponsored symposium was chaired by Mark Thursz, who oversaw a novel news bulletin-themed symposium with sessions provided by a …

This Gilead-sponsored satellite symposium addressed the new and exciting advent of novel therapy in the field of hepatitis C by highlighting recent…

Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and…

A powerful global organisation similar to the one on climate change needs to be established in order to genuinely get to grips with the problem of…

University of British Columbia scientists have uncovered an intricate chain reaction in the body’s immune system and have used the knowledge to develop…